From: N-Acetyl Cysteine improves the diabetic cardiac function: possible role of fibrosis inhibition
Initial weight | Terminal weight | HW | HWI | HR | |
---|---|---|---|---|---|
(g) | (g) | (mg) | (mg/kg, %) | (bpm) | |
Control | 24.32 ± 1.89 | 27.56 ± 2.33 | 168.12 ± 8.37 | 6.11 ± 0.22 | 446 ± 11 |
NAC only | 23.44 ± 0.89 | 25.40 ± 0.54 | 160.40 ± 7.12 | 6.31 ± 0.21 | 448 ± 9 |
NAC1 | 23.22 ± 1.02 | 24.54 ± 0.65* | 150.56 ± 7.07*△ | 6.10 ± 0.18△ | 445 ± 14 |
NAC3 | 23.67 ± 2.03 | 24.36 ± 1.91* | 144.32 ± 13.42* | 5.80 ± 0.25* | 453 ± 21 |
NAC5 | 24.72 ± 1.31 | 24.45 ± 0.97* | 144.00 ± 5.48* | 5.78 ± 0.23* | 440 ± 11 |
NAC7 | 24.86 ± 1.96 | 24.92 ± 1.83* | 143.57 ± 8.94* | 5.77 ± 0.14* | 451 ± 19 |
DM | 24.19 ± 1.60 | 24.84 ± 0.79* | 138.00 ± 4.47* | 5.56 ± 0.26* | 441 ± 9 |
p valuea | 0.347 | 0.940 | 0.668 | 0.066 | 0.61 |